TGFB1 and neoplasm: In response to the chemotherapeutic treatment, the upregulated TGF-β signaling in the CAFs supports the tumor-initiating potential of CSCs, while TGF-β suppression blocks tumor-stroma crosstalk and leads to the attenuation of cancer progression [38].